Click for best price
Recombinant Coagulation Factor Concentrate Market Size, Share 2022
Coagulation factor is the main drug for the treatment of hemophilia, and it has experienced the evolution and development from the first generation blood-derived coagulation factor products to the second generation recombinant products and the third generation long-acting recombinant products. Recombinant coagulation factors avoid the possibility of human infection and get rid of the dependence on plasma; long-acting products improve patient compliance and treatment convenience by prolonging the half-life of drugs, and long-acting recombinant coagulation factors are the trend of future research and development.
This report contains market size and forecasts of Recombinant Coagulation Factor Concentrate in global, including the following market information:
Global Recombinant Coagulation Factor Concentrate Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Recombinant Coagulation Factor Concentrate Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Recombinant Coagulation Factor Concentrate companies in 2021 (%)
The global Recombinant Coagulation Factor Concentrate market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
250 IU Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Recombinant Coagulation Factor Concentrate include Bayer, Alprolix, Benefix, Idelvion, Lxinity, Rebinyn, Rixubis, CSL and Baxalta, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Recombinant Coagulation Factor Concentrate manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Coagulation Factor Concentrate Market, by Dose, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor Concentrate Market Segment Percentages, by Dose, 2021 (%)
250 IU
500 IU
1000 IU
2000 IU
Global Recombinant Coagulation Factor Concentrate Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor Concentrate Market Segment Percentages, by Application, 2021 (%)
Hopistial
Clinic
Others
Global Recombinant Coagulation Factor Concentrate Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Recombinant Coagulation Factor Concentrate Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Coagulation Factor Concentrate revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Recombinant Coagulation Factor Concentrate revenues share in global market, 2021 (%)
Key companies Recombinant Coagulation Factor Concentrate sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Recombinant Coagulation Factor Concentrate sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Alprolix
Benefix
Idelvion
Lxinity
Rebinyn
Rixubis
CSL
Baxalta
Sanofi
Biogen
Pfizer
Novo Disk
Baxter
Wyeth
??????????????
????
????
????
???????????????
| Report Attributes |
Report Details |
| Report Title |
Recombinant Coagulation Factor Concentrate Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
121 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Coagulation Factor Concentrate Market Definition
1.2 Market Segments
1.2.1 Market by Dose
1.2.2 Market by Application
1.3 Global Recombinant Coagulation Factor Concentrate Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Coagulation Factor Concentrate Overall Market Size
2.1 Global Recombinant Coagulation Factor Concentrate Market Size: 2021 VS 2028
2.2 Global Recombinant Coagulation Factor Concentrate Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Recombinant Coagulation Factor Concentrate Sales: 2017-2028
3 Company Landscape
3.1 Top Recombinant Coagulation Factor Concentrate Players in Global Market
3.2 Top Global Recombinant Coagulation Factor Concentrate Companies Ranked by Revenue
3.3 Global Recombinant Coagulation Factor Concentrate Revenue by Companies
3.4 Global Recombinant Coagulation Factor Concentrate Sales by Companies
3.5 Global Recombinant Coagulation Factor Concentrate Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Recombinant Coagulation Factor Concentrate Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Recombinant Coagulation Factor Concentrate Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Coagulation Factor Concentrate Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Coagulation Factor Concentrate Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Coagulation Factor Concentrate Companies
4 Sights by Product
4.1 Overview
4.1.1 By Dose - Global Recombinant Coagulation Factor Concentrate Market Size Markets, 2021 & 2028
4.1.2 250 IU
4.1.3 500 IU
4.1.4 1000 IU
4.1.5 2000 IU
4.2 By Dose - Global Recombinant Coagulation Factor Concentrate Revenue & Forecasts
4.2.1 By Dose - Global Recombinant Coagulation Factor Concentrate Revenue, 2017-2022
4.2.2 By Dose - Global Recombinant Coagulation Factor Concentrate Revenue, 2023-2028
4.2.3 By Dose - Global Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
4.3 By Dose - Global Recombinant Coagulation Factor Concentrate Sales & Forecasts
4.3.1 By Dose - Global Recombinant Coagulation Factor Concentrate Sales, 2017-2022
4.3.2 By Dose - Global Recombinant Coagulation Factor Concentrate Sales, 2023-2028
4.3.3 By Dose - Global Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
4.4 By Dose - Global Recombinant Coagulation Factor Concentrate Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Recombinant Coagulation Factor Concentrate Market Size, 2021 & 2028
5.1.2 Hopistial
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Recombinant Coagulation Factor Concentrate Revenue & Forecasts
5.2.1 By Application - Global Recombinant Coagulation Factor Concentrate Revenue, 2017-2022
5.2.2 By Application - Global Recombinant Coagulation Factor Concentrate Revenue, 2023-2028
5.2.3 By Application - Global Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
5.3 By Application - Global Recombinant Coagulation Factor Concentrate Sales & Forecasts
5.3.1 By Application - Global Recombinant Coagulation Factor Concentrate Sales, 2017-2022
5.3.2 By Application - Global Recombinant Coagulation Factor Concentrate Sales, 2023-2028
5.3.3 By Application - Global Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
5.4 By Application - Global Recombinant Coagulation Factor Concentrate Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Recombinant Coagulation Factor Concentrate Market Size, 2021 & 2028
6.2 By Region - Global Recombinant Coagulation Factor Concentrate Revenue & Forecasts
6.2.1 By Region - Global Recombinant Coagulation Factor Concentrate Revenue, 2017-2022
6.2.2 By Region - Global Recombinant Coagulation Factor Concentrate Revenue, 2023-2028
6.2.3 By Region - Global Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
6.3 By Region - Global Recombinant Coagulation Factor Concentrate Sales & Forecasts
6.3.1 By Region - Global Recombinant Coagulation Factor Concentrate Sales, 2017-2022
6.3.2 By Region - Global Recombinant Coagulation Factor Concentrate Sales, 2023-2028
6.3.3 By Region - Global Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Recombinant Coagulation Factor Concentrate Revenue, 2017-2028
6.4.2 By Country - North America Recombinant Coagulation Factor Concentrate Sales, 2017-2028
6.4.3 US Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.4.4 Canada Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.4.5 Mexico Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Recombinant Coagulation Factor Concentrate Revenue, 2017-2028
6.5.2 By Country - Europe Recombinant Coagulation Factor Concentrate Sales, 2017-2028
6.5.3 Germany Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.5.4 France Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.5.5 U.K. Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.5.6 Italy Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.5.7 Russia Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.5.8 Nordic Countries Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.5.9 Benelux Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Recombinant Coagulation Factor Concentrate Revenue, 2017-2028
6.6.2 By Region - Asia Recombinant Coagulation Factor Concentrate Sales, 2017-2028
6.6.3 China Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.6.4 Japan Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.6.5 South Korea Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.6.6 Southeast Asia Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.6.7 India Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Recombinant Coagulation Factor Concentrate Revenue, 2017-2028
6.7.2 By Country - South America Recombinant Coagulation Factor Concentrate Sales, 2017-2028
6.7.3 Brazil Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.7.4 Argentina Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Coagulation Factor Concentrate Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Recombinant Coagulation Factor Concentrate Sales, 2017-2028
6.8.3 Turkey Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.8.4 Israel Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.8.5 Saudi Arabia Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
6.8.6 UAE Recombinant Coagulation Factor Concentrate Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Recombinant Coagulation Factor Concentrate Major Product Offerings
7.1.4 Bayer Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.1.5 Bayer Key News
7.2 Alprolix
7.2.1 Alprolix Corporate Summary
7.2.2 Alprolix Business Overview
7.2.3 Alprolix Recombinant Coagulation Factor Concentrate Major Product Offerings
7.2.4 Alprolix Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.2.5 Alprolix Key News
7.3 Benefix
7.3.1 Benefix Corporate Summary
7.3.2 Benefix Business Overview
7.3.3 Benefix Recombinant Coagulation Factor Concentrate Major Product Offerings
7.3.4 Benefix Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.3.5 Benefix Key News
7.4 Idelvion
7.4.1 Idelvion Corporate Summary
7.4.2 Idelvion Business Overview
7.4.3 Idelvion Recombinant Coagulation Factor Concentrate Major Product Offerings
7.4.4 Idelvion Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.4.5 Idelvion Key News
7.5 Lxinity
7.5.1 Lxinity Corporate Summary
7.5.2 Lxinity Business Overview
7.5.3 Lxinity Recombinant Coagulation Factor Concentrate Major Product Offerings
7.5.4 Lxinity Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.5.5 Lxinity Key News
7.6 Rebinyn
7.6.1 Rebinyn Corporate Summary
7.6.2 Rebinyn Business Overview
7.6.3 Rebinyn Recombinant Coagulation Factor Concentrate Major Product Offerings
7.6.4 Rebinyn Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.6.5 Rebinyn Key News
7.7 Rixubis
7.7.1 Rixubis Corporate Summary
7.7.2 Rixubis Business Overview
7.7.3 Rixubis Recombinant Coagulation Factor Concentrate Major Product Offerings
7.7.4 Rixubis Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.7.5 Rixubis Key News
7.8 CSL
7.8.1 CSL Corporate Summary
7.8.2 CSL Business Overview
7.8.3 CSL Recombinant Coagulation Factor Concentrate Major Product Offerings
7.8.4 CSL Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.8.5 CSL Key News
7.9 Baxalta
7.9.1 Baxalta Corporate Summary
7.9.2 Baxalta Business Overview
7.9.3 Baxalta Recombinant Coagulation Factor Concentrate Major Product Offerings
7.9.4 Baxalta Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.9.5 Baxalta Key News
7.10 Sanofi
7.10.1 Sanofi Corporate Summary
7.10.2 Sanofi Business Overview
7.10.3 Sanofi Recombinant Coagulation Factor Concentrate Major Product Offerings
7.10.4 Sanofi Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.10.5 Sanofi Key News
7.11 Biogen
7.11.1 Biogen Corporate Summary
7.11.2 Biogen Recombinant Coagulation Factor Concentrate Business Overview
7.11.3 Biogen Recombinant Coagulation Factor Concentrate Major Product Offerings
7.11.4 Biogen Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.11.5 Biogen Key News
7.12 Pfizer
7.12.1 Pfizer Corporate Summary
7.12.2 Pfizer Recombinant Coagulation Factor Concentrate Business Overview
7.12.3 Pfizer Recombinant Coagulation Factor Concentrate Major Product Offerings
7.12.4 Pfizer Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.12.5 Pfizer Key News
7.13 Novo Disk
7.13.1 Novo Disk Corporate Summary
7.13.2 Novo Disk Recombinant Coagulation Factor Concentrate Business Overview
7.13.3 Novo Disk Recombinant Coagulation Factor Concentrate Major Product Offerings
7.13.4 Novo Disk Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.13.5 Novo Disk Key News
7.14 Baxter
7.14.1 Baxter Corporate Summary
7.14.2 Baxter Business Overview
7.14.3 Baxter Recombinant Coagulation Factor Concentrate Major Product Offerings
7.14.4 Baxter Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.14.5 Baxter Key News
7.15 Wyeth
7.15.1 Wyeth Corporate Summary
7.15.2 Wyeth Business Overview
7.15.3 Wyeth Recombinant Coagulation Factor Concentrate Major Product Offerings
7.15.4 Wyeth Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.15.5 Wyeth Key News
7.16 ??????????????
7.16.1 ?????????????? Corporate Summary
7.16.2 ?????????????? Business Overview
7.16.3 ?????????????? Recombinant Coagulation Factor Concentrate Major Product Offerings
7.16.4 ?????????????? Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.16.5 ?????????????? Key News
7.17 ????
7.17.1 ???? Corporate Summary
7.17.2 ???? Business Overview
7.17.3 ???? Recombinant Coagulation Factor Concentrate Major Product Offerings
7.17.4 ???? Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.17.5 ???? Key News
7.18 ????
7.18.1 ???? Corporate Summary
7.18.2 ???? Business Overview
7.18.3 ???? Recombinant Coagulation Factor Concentrate Major Product Offerings
7.18.4 ???? Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.18.5 ???? Key News
7.19 ????
7.19.1 ???? Corporate Summary
7.19.2 ???? Business Overview
7.19.3 ???? Recombinant Coagulation Factor Concentrate Major Product Offerings
7.19.4 ???? Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.19.5 ???? Key News
7.20 ???????????????
7.20.1 ??????????????? Corporate Summary
7.20.2 ??????????????? Business Overview
7.20.3 ??????????????? Recombinant Coagulation Factor Concentrate Major Product Offerings
7.20.4 ??????????????? Recombinant Coagulation Factor Concentrate Sales and Revenue in Global (2017-2022)
7.20.5 ??????????????? Key News
8 Global Recombinant Coagulation Factor Concentrate Production Capacity, Analysis
8.1 Global Recombinant Coagulation Factor Concentrate Production Capacity, 2017-2028
8.2 Recombinant Coagulation Factor Concentrate Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Coagulation Factor Concentrate Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Coagulation Factor Concentrate Supply Chain Analysis
10.1 Recombinant Coagulation Factor Concentrate Industry Value Chain
10.2 Recombinant Coagulation Factor Concentrate Upstream Market
10.3 Recombinant Coagulation Factor Concentrate Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Coagulation Factor Concentrate Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Coagulation Factor Concentrate in Global Market
Table 2. Top Recombinant Coagulation Factor Concentrate Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Recombinant Coagulation Factor Concentrate Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Recombinant Coagulation Factor Concentrate Revenue Share by Companies, 2017-2022
Table 5. Global Recombinant Coagulation Factor Concentrate Sales by Companies, (K Units), 2017-2022
Table 6. Global Recombinant Coagulation Factor Concentrate Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Recombinant Coagulation Factor Concentrate Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Recombinant Coagulation Factor Concentrate Product Type
Table 9. List of Global Tier 1 Recombinant Coagulation Factor Concentrate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Coagulation Factor Concentrate Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Dose ? Global Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2021 & 2028
Table 12. By Dose - Global Recombinant Coagulation Factor Concentrate Revenue (US$, Mn), 2017-2022
Table 13. By Dose - Global Recombinant Coagulation Factor Concentrate Revenue (US$, Mn), 2023-2028
Table 14. By Dose - Global Recombinant Coagulation Factor Concentrate Sales (K Units), 2017-2022
Table 15. By Dose - Global Recombinant Coagulation Factor Concentrate Sales (K Units), 2023-2028
Table 16. By Application ? Global Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Recombinant Coagulation Factor Concentrate Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Recombinant Coagulation Factor Concentrate Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Recombinant Coagulation Factor Concentrate Sales (K Units), 2017-2022
Table 20. By Application - Global Recombinant Coagulation Factor Concentrate Sales (K Units), 2023-2028
Table 21. By Region ? Global Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Recombinant Coagulation Factor Concentrate Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Recombinant Coagulation Factor Concentrate Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Recombinant Coagulation Factor Concentrate Sales (K Units), 2017-2022
Table 25. By Region - Global Recombinant Coagulation Factor Concentrate Sales (K Units), 2023-2028
Table 26. By Country - North America Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Recombinant Coagulation Factor Concentrate Sales, (K Units), 2017-2022
Table 29. By Country - North America Recombinant Coagulation Factor Concentrate Sales, (K Units), 2023-2028
Table 30. By Country - Europe Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Recombinant Coagulation Factor Concentrate Sales, (K Units), 2017-2022
Table 33. By Country - Europe Recombinant Coagulation Factor Concentrate Sales, (K Units), 2023-2028
Table 34. By Region - Asia Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Recombinant Coagulation Factor Concentrate Sales, (K Units), 2017-2022
Table 37. By Region - Asia Recombinant Coagulation Factor Concentrate Sales, (K Units), 2023-2028
Table 38. By Country - South America Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Recombinant Coagulation Factor Concentrate Sales, (K Units), 2017-2022
Table 41. By Country - South America Recombinant Coagulation Factor Concentrate Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Recombinant Coagulation Factor Concentrate Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Recombinant Coagulation Factor Concentrate Sales, (K Units), 2023-2028
Table 46. Bayer Corporate Summary
Table 47. Bayer Recombinant Coagulation Factor Concentrate Product Offerings
Table 48. Bayer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Alprolix Corporate Summary
Table 50. Alprolix Recombinant Coagulation Factor Concentrate Product Offerings
Table 51. Alprolix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Benefix Corporate Summary
Table 53. Benefix Recombinant Coagulation Factor Concentrate Product Offerings
Table 54. Benefix Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Idelvion Corporate Summary
Table 56. Idelvion Recombinant Coagulation Factor Concentrate Product Offerings
Table 57. Idelvion Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Lxinity Corporate Summary
Table 59. Lxinity Recombinant Coagulation Factor Concentrate Product Offerings
Table 60. Lxinity Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Rebinyn Corporate Summary
Table 62. Rebinyn Recombinant Coagulation Factor Concentrate Product Offerings
Table 63. Rebinyn Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Rixubis Corporate Summary
Table 65. Rixubis Recombinant Coagulation Factor Concentrate Product Offerings
Table 66. Rixubis Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. CSL Corporate Summary
Table 68. CSL Recombinant Coagulation Factor Concentrate Product Offerings
Table 69. CSL Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Baxalta Corporate Summary
Table 71. Baxalta Recombinant Coagulation Factor Concentrate Product Offerings
Table 72. Baxalta Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Sanofi Corporate Summary
Table 74. Sanofi Recombinant Coagulation Factor Concentrate Product Offerings
Table 75. Sanofi Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Biogen Corporate Summary
Table 77. Biogen Recombinant Coagulation Factor Concentrate Product Offerings
Table 78. Biogen Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. Pfizer Corporate Summary
Table 80. Pfizer Recombinant Coagulation Factor Concentrate Product Offerings
Table 81. Pfizer Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. Novo Disk Corporate Summary
Table 83. Novo Disk Recombinant Coagulation Factor Concentrate Product Offerings
Table 84. Novo Disk Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. Baxter Corporate Summary
Table 86. Baxter Recombinant Coagulation Factor Concentrate Product Offerings
Table 87. Baxter Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Wyeth Corporate Summary
Table 89. Wyeth Recombinant Coagulation Factor Concentrate Product Offerings
Table 90. Wyeth Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 91. ?????????????? Corporate Summary
Table 92. ?????????????? Recombinant Coagulation Factor Concentrate Product Offerings
Table 93. ?????????????? Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 94. ???? Corporate Summary
Table 95. ???? Recombinant Coagulation Factor Concentrate Product Offerings
Table 96. ???? Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 97. ???? Corporate Summary
Table 98. ???? Recombinant Coagulation Factor Concentrate Product Offerings
Table 99. ???? Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 100. ???? Corporate Summary
Table 101. ???? Recombinant Coagulation Factor Concentrate Product Offerings
Table 102. ???? Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 103. ??????????????? Corporate Summary
Table 104. ??????????????? Recombinant Coagulation Factor Concentrate Product Offerings
Table 105. ??????????????? Recombinant Coagulation Factor Concentrate Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 106. Recombinant Coagulation Factor Concentrate Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 107. Global Recombinant Coagulation Factor Concentrate Capacity Market Share of Key Manufacturers, 2020-2022
Table 108. Global Recombinant Coagulation Factor Concentrate Production by Region, 2017-2022 (K Units)
Table 109. Global Recombinant Coagulation Factor Concentrate Production by Region, 2023-2028 (K Units)
Table 110. Recombinant Coagulation Factor Concentrate Market Opportunities & Trends in Global Market
Table 111. Recombinant Coagulation Factor Concentrate Market Drivers in Global Market
Table 112. Recombinant Coagulation Factor Concentrate Market Restraints in Global Market
Table 113. Recombinant Coagulation Factor Concentrate Raw Materials
Table 114. Recombinant Coagulation Factor Concentrate Raw Materials Suppliers in Global Market
Table 115. Typical Recombinant Coagulation Factor Concentrate Downstream
Table 116. Recombinant Coagulation Factor Concentrate Downstream Clients in Global Market
Table 117. Recombinant Coagulation Factor Concentrate Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Coagulation Factor Concentrate Segment by Dose
Figure 2. Recombinant Coagulation Factor Concentrate Segment by Application
Figure 3. Global Recombinant Coagulation Factor Concentrate Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Recombinant Coagulation Factor Concentrate Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Recombinant Coagulation Factor Concentrate Revenue, 2017-2028 (US$, Mn)
Figure 7. Recombinant Coagulation Factor Concentrate Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Coagulation Factor Concentrate Revenue in 2021
Figure 9. By Dose - Global Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
Figure 10. By Dose - Global Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
Figure 11. By Dose - Global Recombinant Coagulation Factor Concentrate Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
Figure 13. By Application - Global Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
Figure 14. By Application - Global Recombinant Coagulation Factor Concentrate Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
Figure 16. By Region - Global Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
Figure 17. By Country - North America Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
Figure 18. By Country - North America Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
Figure 19. US Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
Figure 24. Germany Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 25. France Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
Figure 33. China Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 37. India Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
Figure 39. By Country - South America Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
Figure 40. Brazil Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Recombinant Coagulation Factor Concentrate Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Recombinant Coagulation Factor Concentrate Sales Market Share, 2017-2028
Figure 44. Turkey Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Recombinant Coagulation Factor Concentrate Revenue, (US$, Mn), 2017-2028
Figure 48. Global Recombinant Coagulation Factor Concentrate Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Recombinant Coagulation Factor Concentrate by Region, 2021 VS 2028
Figure 50. Recombinant Coagulation Factor Concentrate Industry Value Chain
Figure 51. Marketing Channels
